HGB-212: A Phase 3 Single Arm Study Evaluating the Efficacy and Safety of Gene Therapy in Subjects with Transfusion-dependent ?-Thalassemia, who have a B0/B0 Genotype, by Transplantation of Autologous CD34+ Stem Cells Transduce